ANDA 214256, held by Sun Pharm. Chlorpromazine Hydrochloride.
As of Nov 16, 2026, ANDA 214256 (Chlorpromazine Hydrochloride), held by Sun Pharm, was first approved by FDA on Oct 26, 2020, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 26, 2020 | Original application | Approved | None posted |
| Chlorpromazine Hydrochloride10MG · tablet;oral | Chlorpromazine Hydrochloride | Discontinued |
| Chlorpromazine Hydrochloride25MG · tablet;oral | Chlorpromazine Hydrochloride | Discontinued |
| Chlorpromazine Hydrochloride50MG · tablet;oral | Chlorpromazine Hydrochloride | Discontinued |
| Chlorpromazine Hydrochloride100MG · tablet;oral | Chlorpromazine Hydrochloride | Discontinued |
| Chlorpromazine Hydrochloride200MG · tablet;oral | Chlorpromazine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters